XML 39 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Reconciliation of the Difference between the Benefit for Income Taxes and Income Taxes at the Statutory U.S. Federal Income Tax Rate
A reconciliation of the difference between the benefit for income taxes and income taxes at the statutory U.S. federal income tax rate is as follows for the years ended December 31, 2015, 2014, and 2013 (in thousands, except percentages):
 
2015
 
2014
 
2013
 
Amount
 
% of Pretax
Earnings
 
Amount
 
% of Pretax
Earnings
 
Amount
 
% of Pretax
Earnings
Income tax benefit at statutory rate
$
(39,907
)
 
34.0
 %
 
$
(20,166
)
 
34.0
 %
 
$
(12,392
)
 
34.0
 %
State income taxes
(2,176
)
 
1.9
 %
 
(1,343
)
 
2.3
 %
 
(852
)
 
2.3
 %
Research and development credits
(5,698
)
 
4.9
 %
 
(2,577
)
 
4.3
 %
 
(2,265
)
 
6.2
 %
Foreign rate differential
2

 
 %
 

 
 %
 

 
 %
Permanent items
3,687

 
(3.1
)%
 
1,525

 
(2.6
)%
 
3,060

 
(8.4
)%
Provision to return adjustments
(426
)
 
0.2
 %
 
64

 
(0.1
)%
 
320

 
(0.9
)%
Effect of change in state tax rate
932

 
(0.8
)%
 
2

 
 %
 
(1
)
 
 %
Increase in unrecognized tax benefits
950

 
(0.8
)%
 
425

 
(0.7
)%
 
566

 
(1.5
)%
Change in valuation allowance
42,636

 
(36.3
)%
 
22,070

 
(37.2
)%
 
11,564

 
(31.7
)%
Net benefit
$

 
 %
 
$

 
 %
 
$

 
 %
Components of Deferred Tax Assets and Liabilities
The components of deferred tax assets and liabilities at December 31, 2015 and 2014 were as follows (in thousands):
 
December 31,
 
2015
 
2014
Deferred tax assets:
 

 
 

     Domestic net operating loss carryforwards
$
93,923

 
$
59,312

     Foreign net operating loss carryforwards
2

 

     Research and development expenses
1,289

 
405

     Capitalized Section 174 expenses
51

 
57

     Research and development credits
8,889

 
4,572

     Accrued bonuses
822

 
1,066

     Share-based compensation
3,671

 
1,045

     Other
604

 
135

          Total gross deferred tax assets
109,251

 
66,592

          Valuation allowance
(109,111
)
 
(66,475
)
               Total deferred tax assets
140

 
117

Deferred tax liabilities:
 

 
 

     Other
(140
)
 
(117
)
               Total deferred tax liabilities
(140
)
 
(117
)
                    Total deferred tax assets and liabilities, net
$

 
$

Summary of Uncertain Tax Benefit
Therefore, the Company recognized an uncertain tax benefit associated with the federal R&D credit carryover during the years ended December 31, 2015 and 2014, as follows (in thousands):
Balance at December 31, 2013
$
581

     Increases related to 2014
425

     Increases related to prior periods

Balance at December 31, 2014
1,006

     Increases related to 2015
940

     Increases related to prior periods
10

Balance at December 31, 2015
$
1,956